Zhou H, Zhao H, Hou X, Wang Y, et al. Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study. J Clin Oncol 2026 Mar 4:JCO2501929. doi: 10.1200/JCO-25-01929.
PMID: 41779981